Abstract
The present study documents major histocompatibility complex (MHC) Class I and II expression during early acute rejection of human liver grafts. Serial graft biopsies (pretransplant, time zero, and 1 week) were studied. Ten patients received azathioprine (AZA) and prednisone; the other six patients were treated with quadruple therapy (azathioprine, cyclosporine A, prednisone, and cyclophosphamide). To study the specificity of changes in MHC antigen expression, biopsies of six patients with minor or no morphologic abnormalities served as controls. In addition, phenotypes of inflammatory cells present during rejection were analyzed using a panel of monoclonal antibodies. The results show that during acute rejection expression of MHC Class I and II antigens increased significantly in the AZA-treated patients, in a pattern similar to that seen in the patients treated with quadruple therapy, showing enhanced MHC Class I expression on hepatocytes, bile duct epithelium, and sinusoidal endothelium, and Class II antigen on Kupffer cells and sinusoidal endothelium. Bile duct epithelium was consistently positive for Class II antigen; no significant difference with the nonrejection group was observed. T cells are the predominant inflammatory cells during rejection with equal quantities of CD4+ and CD8+ cells. A majority of the infiltrating T cells show expression of Class II antigen but do not react with anti-interleukin-2 receptor antibody. This may be the result of immunosuppressive therapy or a simple reflection of the temporary expression of interleukin-2 receptors during lymphocyte activation. The authors hypothesize that the induction of MHC antigens on bile duct epithelium leads to rejection whereas the expression on hepatocytes represents an epiphenomenon.
Full text
PDF












Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bach F. H., Sachs D. H. Current concepts: immunology. Transplantation immunology. N Engl J Med. 1987 Aug 20;317(8):489–492. doi: 10.1056/NEJM198708203170807. [DOI] [PubMed] [Google Scholar]
- Ballardini G., Mirakian R., Bianchi F. B., Pisi E., Doniach D., Bottazzo G. F. Aberrant expression of HLA-DR antigens on bileduct epithelium in primary biliary cirrhosis: relevance to pathogenesis. Lancet. 1984 Nov 3;2(8410):1009–1013. doi: 10.1016/s0140-6736(84)91108-5. [DOI] [PubMed] [Google Scholar]
- Barbatis C., Woods J., Morton J. A., Fleming K. A., McMichael A., McGee J. O. Immunohistochemical analysis of HLA (A, B, C) antigens in liver disease using a monoclonal antibody. Gut. 1981 Dec;22(12):985–991. doi: 10.1136/gut.22.12.985. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Baudot P., Capron-Laudereau M., Emond J., Gane P., Rouger P., Houssin D. Early disappearance of donor-specific immunofluorescence in spontaneously tolerated liver allografts in inbred rats. Transplant Proc. 1987 Feb;19(1 Pt 1):200–204. [PubMed] [Google Scholar]
- Bosman F. T., Lindeman J., Kuiper G., van der Wal A., Kreunig J. The influence of fixation on immunoperoxidase staining of plasmacells in paraffin sections of intestinal biopsy specimens. Histochemistry. 1977 Jul 18;53(1):57–62. doi: 10.1007/BF00511210. [DOI] [PubMed] [Google Scholar]
- Demetris A. J., Lasky S., Van Thiel D. H., Starzl T. E., Whiteside T. Induction of DR/IA antigens in human liver allografts. An immunocytochemical and clinicopathologic analysis of twenty failed grafts. Transplantation. 1985 Nov;40(5):504–509. doi: 10.1097/00007890-198511000-00007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fukusato T., Gerber M. A., Thung S. N., Ferrone S., Schaffner F. Expression of HLA class I antigens on hepatocytes in liver disease. Am J Pathol. 1986 May;123(2):264–270. [PMC free article] [PubMed] [Google Scholar]
- Gassel H. J., Engemann R., Thiede A., Hamelmann H. Replacement of donor Kupffer cells by recipient cells after orthotopic rat liver transplantation. Transplant Proc. 1987 Feb;19(1 Pt 1):351–353. [PubMed] [Google Scholar]
- Gouw A. S., Houthoff H. J., Huitema S., Beelen J. M., Gips C. H., Poppema S. Expression of major histocompatibility complex antigens and replacement of donor cells by recipient ones in human liver grafts. Transplantation. 1987 Feb;43(2):291–296. doi: 10.1097/00007890-198702000-00025. [DOI] [PubMed] [Google Scholar]
- Hall B. M. Cellular infiltrates in allografts. Transplant Proc. 1987 Feb;19(1 Pt 1):50–56. [PubMed] [Google Scholar]
- Halloran P. F., Wadgymar A., Autenried P. The regulation of expression of major histocompatibility complex products. Transplantation. 1986 Apr;41(4):413–420. [PubMed] [Google Scholar]
- Hodgkin P. D., Hapel A. J., Johnson R. M., Young I. G., Lafferty K. J. Blocking of delivery of the antigen-mediated signal to the nucleus of T cells by cyclosporine. Transplantation. 1987 May;43(5):685–692. doi: 10.1097/00007890-198705000-00017. [DOI] [PubMed] [Google Scholar]
- Koene R. A., de Waal R. M., Bogman M. J. Variable expression of major histocompatibility antigens: role in transplantation immunology. Kidney Int. 1986 Jul;30(1):1–8. doi: 10.1038/ki.1986.142. [DOI] [PubMed] [Google Scholar]
- Krom R. A., Wiesner R. H., Haagsma E. B., Ludwig J., Gips C. H., Grond A. J., Houthoff H. J. A comparison of azathioprine and cyclosporine in liver transplantation: a study of two personal series. Transplant Proc. 1987 Feb;19(1 Pt 3):2440–2442. [PubMed] [Google Scholar]
- Lechler R. I., Batchelor J. R. Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells. J Exp Med. 1982 Jan 1;155(1):31–41. doi: 10.1084/jem.155.1.31. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Milton A. D., Fabre J. W. Massive induction of donor-type class I and class II major histocompatibility complex antigens in rejecting cardiac allografts in the rat. J Exp Med. 1985 Jan 1;161(1):98–112. doi: 10.1084/jem.161.1.98. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Montano L., Miescher G. C., Goodall A. H., Wiedmann K. H., Janossy G., Thomas H. C. Hepatitis B virus and HLA antigen display in the liver during chronic hepatitis B virus infection. Hepatology. 1982 Sep-Oct;2(5):557–561. doi: 10.1002/hep.1840020508. [DOI] [PubMed] [Google Scholar]
- Nagafuchi Y., Hobbs K. E., Thomas H. C., Scheuer P. J. Expression of beta-2-microglobulin on hepatocytes after liver transplantation. Lancet. 1985 Mar 9;1(8428):551–554. doi: 10.1016/s0140-6736(85)91209-7. [DOI] [PubMed] [Google Scholar]
- Poppema S., Hollema H., Visser L., Vos H. Monoclonal antibodies (MT1, MT2, MB1, MB2, MB3) reactive with leukocyte subsets in paraffin-embedded tissue sections. Am J Pathol. 1987 Jun;127(3):418–429. [PMC free article] [PubMed] [Google Scholar]
- Snyder D. S., Wright C. L., Ting C. Inhibition of human monocyte antigen presentation, but not HLA-DR expression, by cyclosporine. Transplantation. 1987 Sep;44(3):407–411. doi: 10.1097/00007890-198709000-00016. [DOI] [PubMed] [Google Scholar]
- So S. K., Platt J. L., Ascher N. L., Snover D. C. Increased expression of class I major histocompatibility complex antigens on hepatocytes in rejecting human liver allografts. Transplantation. 1987 Jan;43(1):79–85. doi: 10.1097/00007890-198701000-00018. [DOI] [PubMed] [Google Scholar]
- Takacs L., Szende B., Monostori E., Rot A., Lapis K., Szecseny A., Ando I. Expression of HLA-DR antigens on bileduct cells of rejected liver transplant. Lancet. 1983 Dec 24;2(8365-66):1500–1500. doi: 10.1016/s0140-6736(83)90845-0. [DOI] [PubMed] [Google Scholar]
- Unanue E. R., Allen P. M. Comment on the finding of Ia expression in nonlymphoid cells. Lab Invest. 1986 Aug;55(2):123–125. [PubMed] [Google Scholar]
- Waldmann T. A. The structure, function, and expression of interleukin-2 receptors on normal and malignant lymphocytes. Science. 1986 May 9;232(4751):727–732. doi: 10.1126/science.3008337. [DOI] [PubMed] [Google Scholar]




